Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Charles Theillet

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Physiology

Chemicals & Drugs

Anatomy

Genes & Molecular Sequences

Procedures

Concepts & Ideas

Molecular Sequence Data

Phenomena

Nucleic Acid Hybridization

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Tuduri Sandie; Crabbé Laure; Conti Chiara; Tourrière Hélène; Holtgreve-Grez Heidi; Jauch Anna; Pantesco Véronique; De Vos John; Thomas Aubin; Theillet Charles; Pommier Yves; Tazi Jamal; Coquelle Arnaud; Pasero Philippe
Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription.
Chanrion Maïa; Negre Vincent; Fontaine Hélène; Salvetat Nicolas; Bibeau Frédéric; Mac Grogan Gaëtan; Mauriac Louis; Katsaros Dionyssios; Molina Franck; Theillet Charles; Darbon Jean-Marie
A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer.
Chanrion Maïa; Fontaine Hélène; Rodriguez Carmen; Negre Vincent; Bibeau Frédéric; Theillet Charles; Hénaut Alain; Darbon Jean-Marie
A new molecular breast cancer subclass defined from a large scale real-time quantitative RT-PCR study.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Charles Theillet (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Tuduri Sandie; Crabbé Laure; Conti Chiara; Tourrière Hélène; Holtgreve-Grez Heidi; Jauch Anna; Pantesco Véronique; De Vos John; Thomas Aubin; Theillet Charles; Pommier Yves; Tazi Jamal; Coquelle Arnaud; Pasero Philippe
Topoisomerase I suppresses genomic instability by preventing interference between replication and transcription.
Nature cell biology 2009;11(11):1315-24.
2008: Chanrion Maïa; Negre Vincent; Fontaine Hélène; Salvetat Nicolas; Bibeau Frédéric; Mac Grogan Gaëtan; Mauriac Louis; Katsaros Dionyssios; Molina Franck; Theillet Charles; Darbon Jean-Marie
A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(6):1744-52.
2007: Chanrion Maïa; Fontaine Hélène; Rodriguez Carmen; Negre Vincent; Bibeau Frédéric; Theillet Charles; Hénaut Alain; Darbon Jean-Marie
A new molecular breast cancer subclass defined from a large scale real-time quantitative RT-PCR study.
BMC cancer 2007;7():39.
2006: Orsetti B; Nugoli M; Cervera N; Lasorsa L; Chuchana P; Rougé C; Ursule L; Nguyen C; Bibeau F; Rodriguez C; Theillet C
Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q.
British journal of cancer 2006;95(10):1439-47.
2006: Côme Christophe; Magnino Fabrice; Bibeau Frédéric; De Santa Barbara Pascal; Becker Karl Friedrich; Theillet Charles; Savagner Pierre
Snail and slug play distinct roles during breast carcinoma progression.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(18):5395-402.
2006: El Messaoudi Selma; Fabbrizio Eric; Rodriguez Carmen; Chuchana Paul; Fauquier Lucas; Cheng Donghang; Theillet Charles; Vandel Laurence; Bedford Mark T; Sardet Claude
Coactivator-associated arginine methyltransferase 1 (CARM1) is a positive regulator of the Cyclin E1 gene.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(36):13351-6.
2006: Olivier Magali; Langerød Anita; Carrieri Patrizia; Bergh Jonas; Klaar Sigrid; Eyfjord Jorunn; Theillet Charles; Rodriguez Carmen; Lidereau Rosette; Bièche Ivan; Varley Jennifer; Bignon Yves; Uhrhammer Nancy; Winqvist Robert; Jukkola-Vuorinen Arja; Niederacher Dieter; Kato Shunsuke; Ishioka Chikashi; Hainaut Pierre; Børresen-Dale Anne-Lise
The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(4):1157-67.
2006: Moll F; Millet C; Noël D; Orsetti B; Bardin A; Katsaros D; Jorgensen C; Garcia M; Theillet C; Pujol P; François V
Chordin is underexpressed in ovarian tumors and reduces tumor cell motility.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006;20(2):240-50.
2005: Gelsi-Boyer Véronique; Orsetti Béatrice; Cervera Nathalie; Finetti Pascal; Sircoulomb Fabrice; Rougé Carole; Lasorsa Laurence; Letessier Anne; Ginestier Christophe; Monville Florence; Esteyriès Séverine; Adélaïde José; Esterni Benjamin; Henry Catherine; Ethier Stephen P; Bibeau Frédéric; Mozziconacci Marie-Joëlle; Charafe-Jauffret Emmanuelle; Jacquemier Jocelyne; Bertucci François; Birnbaum Daniel; Theillet Charles; Chaffanet Max
Comprehensive profiling of 8p11-12 amplification in breast cancer.
Molecular cancer research : MCR 2005;3(12):655-67.
2004: Orsetti Béatrice; Nugoli Mélanie; Cervera Nathalie; Lasorsa Laurence; Chuchana Paul; Ursule Lisa; Nguyen Catherine; Redon Richard; du Manoir Stanislas; Rodriguez Carmen; Theillet Charles
Genomic and expression profiling of chromosome 17 in breast cancer reveals complex patterns of alterations and novel candidate genes.
Cancer research 2004;64(18):6453-60.
2004: Rodriguez Carmen; Hughes-Davies Luke; Vallès Hélène; Orsetti Béatrice; Cuny Marguerite; Ursule Lisa; Kouzarides Tony; Theillet Charles
Amplification of the BRCA2 pathway gene EMSY in sporadic breast cancer is related to negative outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(17):5785-91.
2004: Vendrell J A; Magnino F; Danis E; Duchesne M J; Pinloche S; Pons M; Birnbaum D; Nguyen C; Theillet C; Cohen P A
Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation.
Journal of molecular endocrinology 2004;32(2):397-414.
2003: Hughes-Davies Luke; Huntsman David; Ruas Margarida; Fuks Francois; Bye Jacqueline; Chin Suet-Feung; Milner Jonathon; Brown Lindsay A; Hsu Forrest; Gilks Blake; Nielsen Torsten; Schulzer Michael; Chia Stephen; Ragaz Joseph; Cahn Anthony; Linger Lori; Ozdag Hilal; Cattaneo Elena; Jordanova E S; Schuuring Edward; Yu David S; Venkitaraman Ashok; Ponder Bruce; Doherty Aidan; Aparicio Samuel; Bentley David; Theillet Charles; Ponting Chris P; Caldas Carlos; Kouzarides Tony
EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer.
Cell 2003;115(5):523-35.
2003: Adélaïde José; Huang Huai-En; Murati Anne; Alsop Amber E; Orsetti Béatrice; Mozziconacci Marie-Joëlle; Popovici Cornel; Ginestier Christophe; Letessier Anne; Basset Céline; Courtay-Cahen Céline; Jacquemier Jocelyne; Theillet Charles; Birnbaum Daniel; Edwards Paul A W; Chaffanet Max
A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene.
Genes, chromosomes & cancer 2003;37(4):333-45.
2003: Uhrhammer Nancy; Theillet Charles
[Genes and cancer. CHK2 (CDS1, Rad53): tumor suppressor gene]
Bulletin du cancer 2003;90(7):581-2.
2003: Nugoli Mélanie; Chuchana Paul; Vendrell Julie; Orsetti Béatrice; Ursule Lisa; Nguyen Catherine; Birnbaum Daniel; Douzery Emmanuel J P; Cohen Pascale; Theillet Charles
Genetic variability in MCF-7 sublines: evidence of rapid genomic and RNA expression profile modifications.
BMC cancer 2003;3():13.
2003: Mazars Georges-Raoul; Theillet Charles
Direct sequencing by thermal asymmetric PCR.
Methods in molecular biology (Clifton, N.J.) 2003;226():355-60.
2002: Janssen Johannes W G; Cuny Marguerite; Orsetti Béatrice; Rodriguez Carmen; Vallés Hélène; Bartram Claus R; Schuuring Ed; Theillet Charles
MYEOV: a candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancer.
International journal of cancer. Journal international du cancer 2002;102(6):608-14.
2002: Popovici Cornel; Basset Céline; Bertucci François; Orsetti Béatrice; Adélaide José; Mozziconacci Marie-Joëlle; Conte Nathalie; Murati Anne; Ginestier Christophe; Charafe-Jauffret Emmanuelle; Ethier Stephen P; Lafage-Pochitaloff Marina; Theillet Charles; Birnbaum Daniel; Chaffanet Max
Reciprocal translocations in breast tumor cell lines: cloning of a t(3;20) that targets the FHIT gene.
Genes, chromosomes & cancer 2002;35(3):204-18.
2002: Suspitsin E N; Grigoriev M Y; Togo A V; Kuligina E S; Belogubova E V; Pozharisski K M; Chagunava O L; Sokolov E P; Theillet C; Berstein L M; Hanson K P; Imyanitov E N
Distinct prevalence of the CYP19 Delta3(TTTA)(7) allele in premenopausal versus postmenopausal breast cancer patients, but not in control individuals.
European journal of cancer (Oxford, England : 1990) 2002;38(14):1911-6.
2002: Imyanitov Evgeny N; Suspitsin Evgeny N; Grigoriev Maxim Yu; Togo Alexandr V; Kuligina Ekatherina Sh; Belogubova Evgeniya V; Pozharisski Kazymir M; Turkevich Elena A; Rodriquez Carmen; Cornelisse Cees J; Hanson Kaido P; Theillet Charles
Concordance of allelic imbalance profiles in synchronous and metachronous bilateral breast carcinomas.
International journal of cancer. Journal international du cancer 2002;100(5):557-64.
2002: Rodriguez Carmen; Vallès Hélène; Causse Annick; Johannsdottir Vala; Eliaou Jean-François; Theillet Charles
Involvement of ATM missense variants and mutations in a series of unselected breast cancer cases.
Genes, chromosomes & cancer 2002;33(2):141-9.
2001: Theillet C; Orsetti B; Redon R; Manoir S D
[Genomic profiling: from molecular cytogenetics to DNA arrays]
Bulletin du cancer 2001;88(3):261-8.
2000: Davidson J M; Gorringe K L; Chin S F; Orsetti B; Besret C; Courtay-Cahen C; Roberts I; Theillet C; Caldas C; Edwards P A
Molecular cytogenetic analysis of breast cancer cell lines.
British journal of cancer 2000;83(10):1309-17.
2000: Kuligina E S; Togo A V; Suspitsin E N; Grigoriev M Y; Pozharisskiy K M; Chagunava O L; Berstein L M; Theillet C; Hanson K P; Imyanitov E N
CYP17 polymorphism in the groups of distinct breast cancer susceptibility: comparison of patients with the bilateral disease vs. monolateral breast cancer patients vs. middle-aged female controls vs. elderly tumor-free women.
Cancer letters 2000;156(1):45-50.
2000: Imyanitov E N; Togo A V; Suspitsin E N; Grigoriev M Y; Pozharisski K M; Turkevich E A; Hanson K P; Hayward N K; Chenevix-Trench G; Theillet C; Lavin M F
Evidence for microsatellite instability in bilateral breast carcinomas.
Cancer letters 2000;154(1):9-17.
2000: Polanowska J; Le Cam L; Orsetti B; Vallés H; Fabbrizio E; Fajas L; Taviaux S; Theillet C; Sardet C
Human E2F5 gene is oncogenic in primary rodent cells and is amplified in human breast tumors.
Genes, chromosomes & cancer 2000;28(1):126-30.
2000: Cuny M; Kramar A; Courjal F; Johannsdottir V; Iacopetta B; Fontaine H; Grenier J; Culine S; Theillet C
Relating genotype and phenotype in breast cancer: an analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations.
Cancer research 2000;60(4):1077-83.
2000: Rodriguez C; Causse A; Ursule E; Theillet C
At least five regions of imbalance on 6q in breast tumors, combining losses and gains.
Genes, chromosomes & cancer 2000;27(1):76-84.
1999: Orsetti B; Courjal F; Cuny M; Rodriguez C; Theillet C
17q21-q25 aberrations in breast cancer: combined allelotyping and CGH analysis reveals 5 regions of allelic imbalance among which two correspond to DNA amplification.
Oncogene 1999;18(46):6262-70.
1998: Bautista S; Vallès H; Walker R L; Anzick S; Zeillinger R; Meltzer P; Theillet C
In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(12):2925-9.
1998: Olivier M; Bautista S; Vallès H; Theillet C
Relaxed cell-cycle arrests and propagation of unrepaired chromosomal damage in cancer cell lines with wild-type p53.
Molecular carcinogenesis 1998;23(1):1-12.
1998: Bautista S; Theillet C
CCND1 and FGFR1 coamplification results in the colocalization of 11q13 and 8p12 sequences in breast tumor nuclei.
Genes, chromosomes & cancer 1998;22(4):268-77.
1998: Phelan C M; Borg A; Cuny M; Crichton D N; Baldersson T; Andersen T I; Caligo M A; Lidereau R; Lindblom A; Seitz S; Kelsell D; Hamann U; Rio P; Thorlacius S; Papp J; Olah E; Ponder B; Bignon Y J; Scherneck S; Barkardottir R; Borresen-Dale A L; Eyfjörd J; Theillet C; Thompson A M; Larsson C
Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
Cancer research 1998;58(5):1004-12.
1997: Bautista S; Theillet C
p53 mutations in breast cancer: incidence and relations to tumor aggressiveness and evolution of the disease.
Pathologie-biologie 1997;45(10):882-92.
1997: Courjal F; Theillet C
Comparative genomic hybridization analysis of breast tumors with predetermined profiles of DNA amplification.
Cancer research 1997;57(19):4368-77.
1997: Courjal F; Cuny M; Simony-Lafontaine J; Louason G; Speiser P; Zeillinger R; Rodriguez C; Theillet C
Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups.
Cancer research 1997;57(19):4360-7.
1997: Courjal F; Chuchana P; Theillet C; Fort P
Structure and chromosomal assignment to 22q12 and 17qter of the ras-related Rac2 and Rac3 human genes.
Genomics 1997;44(2):242-6.
1997: Bekri S; Adélaïde J; Merscher S; Grosgeorge J; Caroli-Bosc F; Perucca-Lostanlen D; Kelley P M; Pébusque M J; Theillet C; Birnbaum D; Gaudray P
Detailed map of a region commonly amplified at 11q13-->q14 in human breast carcinoma.
Cytogenetics and cell genetics 1997;79(1-2):125-31.
1996: Courjal F; Cuny M; Rodriguez C; Louason G; Speiser P; Katsaros D; Tanner M M; Zeillinger R; Theillet C
DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours.
British journal of cancer 1996;74(12):1984-9.
1996: Noviello C; Courjal F; Theillet C
Loss of heterozygosity on the long arm of chromosome 6 in breast cancer: possibly four regions of deletion.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(9):1601-6.
1996: Courjal F; Louason G; Speiser P; Katsaros D; Zeillinger R; Theillet C
Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors.
International journal of cancer. Journal international du cancer 1996;69(4):247-53.
1995: Børresen A L; Andersen T I; Eyfjörd J E; Cornelis R S; Thorlacius S; Borg A; Johansson U; Theillet C; Scherneck S; Hartman S
TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains.
Genes, chromosomes & cancer 1995;14(1):71-5.
1995: Katsaros D; Theillet C; Zola P; Louason G; Sanfilippo B; Isaia E; Arisio R; Giardina G; Sismondi P
Concurrent abnormal expression of erbB-2, myc and ras genes is associated with poor outcome of ovarian cancer patients.
Anticancer research 1995;15(4):1501-10.
1995: Moyret-Lalle C; Marçais C; Jacquemier J; Moles J P; Daver A; Soret J Y; Jeanteur P; Ozturk M; Theillet C
ras, p53 and HPV status in benign and malignant prostate tumors.
International journal of cancer. Journal international du cancer 1995;64(2):124-9.
1995: Dib A; Adélaïde J; Chaffanet M; Imbert A; Le Paslier D; Jacquemier J; Gaudray P; Theillet C; Birnbaum D; Pébusque M J
Characterization of the region of the short arm of chromosome 8 amplified in breast carcinoma.
Oncogene 1995;10(5):995-1001.
1995: Madsen M W; Moyret C; Theillet C; Briand P
Growth factor requirement, oncogene expression and TP53 mutations of a tumorigenic and a non-tumorigenic subline of the human breast carcinoma cell line, HMT-3909.
European journal of cancer (Oxford, England : 1990) 1995;31A(3):362-7.
1995: Rodriguez C; Grosgeorge J; Nguyen V C; Gaudray P; Theillet C
Human gp130 transducer chain gene (IL6ST) is localized to chromosome band 5q11 and possesses a pseudogene on chromosome band 17p11.
Cytogenetics and cell genetics 1995;70(1-2):64-7.
1994: Moyret C; Madsen M W; Cooke J; Briand P; Theillet C
Gradual selection of a cellular clone presenting a mutation at codon 179 of the p53 gene during establishment of the immortalized human breast epithelial cell line HMT-3522.
Experimental cell research 1994;215(2):380-5.
1994: Moyret C; Theillet C; Puig P L; Molés J P; Thomas G; Hamelin R
Relative efficiency of denaturing gradient gel electrophoresis and single strand conformation polymorphism in the detection of mutations in exons 5 to 8 of the p53 gene.
Oncogene 1994;9(6):1739-43.
1994: Jacquemier J; Molès J P; Penault-Llorca F; Adélaide J; Torrente M; Viens P; Birnbaum D; Theillet C
p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results.
British journal of cancer 1994;69(5):846-52.
1994: Rodriguez C; Theillet C; Portier M; Bataille R; Klein B
Molecular analysis of the IL-6 receptor in human multiple myeloma, an IL-6-related disease.
FEBS letters 1994;341(2-3):156-61.
1994: Kirchweger R; Zeillinger R; Schneeberger C; Speiser P; Louason G; Theillet C
Patterns of allele losses suggest the existence of five distinct regions of LOH on chromosome 17 in breast cancer.
International journal of cancer. Journal international du cancer 1994;56(2):193-9.
1994: Karlseder J; Zeillinger R; Schneeberger C; Czerwenka K; Speiser P; Kubista E; Birnbaum D; Gaudray P; Theillet C
Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer.
Genes, chromosomes & cancer 1994;9(1):42-8.
1993: Theillet C; Adelaide J; Louason G; Bonnet-Dorion F; Jacquemier J; Adnane J; Longy M; Katsaros D; Sismondi P; Gaudray P
FGFRI and PLAT genes and DNA amplification at 8p12 in breast and ovarian cancers.
Genes, chromosomes & cancer 1993;7(4):219-26.
1993: Molès J P; Theillet C; Basset-Sèguin N; Guilhou J J
Mutation of the tumor suppressor gene TP53 is not detected in psoriatic skin.
The Journal of investigative dermatology 1993;101(1):100-2.
1993: Molès J P; Moyret C; Guillot B; Jeanteur P; Guilhou J J; Theillet C; Basset-Sèguin N
p53 gene mutations in human epithelial skin cancers.
Oncogene 1993;8(3):583-8.
1992: Portier M; Molès J P; Mazars G R; Jeanteur P; Bataille R; Klein B; Theillet C
p53 and RAS gene mutations in multiple myeloma.
Oncogene 1992;7(12):2539-43.
1992: Szepetowski P; Ollendorff V; Grosgeorge J; Courseaux A; Birnbaum D; Theillet C; Gaudray P
DNA amplification at 11q13.5-q14 in human breast cancer.
Oncogene 1992;7(12):2513-7.
1992: Mazars R; Spinardi L; BenCheikh M; Simony-Lafontaine J; Jeanteur P; Theillet C
p53 mutations occur in aggressive breast cancer.
Cancer research 1992;52(14):3918-23.
1992: Cheickh M B; Rouanet P; Louason G; Jeanteur P; Theillet C
An attempt to define sets of cooperating genetic alterations in human breast cancer.
International journal of cancer. Journal international du cancer 1992;51(4):542-7.
1992: Gaudray P; Szepetowski P; Escot C; Birnbaum D; Theillet C
DNA amplification at 11q13 in human cancer: from complexity to perplexity.
Mutation research 1992;276(3):317-28.
1992: Mazars G R; Portier M; Zhang X G; Jourdan M; Bataille R; Theillet C; Klein B
Mutations of the p53 gene in human myeloma cell lines.
Oncogene 1992;7(5):1015-8.
1992: Szepetowski P; Simon M P; Grosgeorge J; Huebner K; Bastard C; Evans G A; Tsujimoto Y; Birnbaum D; Theillet C; Gaudray P
Localization of 11q13 loci with respect to regional chromosomal breakpoints.
Genomics 1992;12(4):738-44.
1992: Mazars G R; Jeanteur P; Lynch H T; Lenoir G; Theillet C
Nucleotide sequence polymorphism in a hotspot mutation region of the p53 gene.
Oncogene 1992;7(4):781-2.
1992: Szepetowski P; Courseaux A; Carle G F; Theillet C; Gaudray P
Amplification of 11q13 DNA sequences in human breast cancer: D11S97 identifies a region tightly linked to BCL1 which can be amplified separately.
Oncogene 1992;7(4):751-5.
1991: Mazars R; Pujol P; Maudelonde T; Jeanteur P; Theillet C
p53 mutations in ovarian cancer: a late event?
Oncogene 1991;6(9):1685-90.
1991: Mazars G R; Moyret C; Jeanteur P; Theillet C G
Direct sequencing by thermal asymmetric PCR.
Nucleic acids research 1991;19(17):4783.
1991: Spinardi L; Mazars R; Theillet C
Protocols for an improved detection of point mutations by SSCP.
Nucleic acids research 1991;19(14):4009.
1991: Szepetowski P; Nguyen C; Perucca-Lostanlen D; Carle G F; Tsujimoto Y; Birnbaum D; Theillet C; Gaudray P
D11S146 and BCL1 are physically linked but can be discriminated by their amplification status in human breast cancer.
Genomics 1991;10(2):410-6.
1991: Adnane J; Gaudray P; Dionne C A; Crumley G; Jaye M; Schlessinger J; Jeanteur P; Birnbaum D; Theillet C
BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers.
Oncogene 1991;6(4):659-63.
1991: Le Roy X; Escot C; Brouillet J P; Theillet C; Maudelonde T; Simony-Lafontaine J; Pujol H; Rochefort H
Decrease of c-erbB-2 and c-myc RNA levels in tamoxifen-treated breast cancer.
Oncogene 1991;6(3):431-7.
1990: Brouillet J P; Theillet C; Maudelonde T; Defrenne A; Simony-Lafontaine J; Sertour J; Pujol H; Jeanteur P; Rochefort H
Cathepsin D assay in primary breast cancer and lymph nodes: relationship with c-myc, c-erb-B-2 and int-2 oncogene amplification and node invasiveness.
European journal of cancer (Oxford, England : 1990) 1990;26(4):437-41.
1990: Theillet C; Adnane J; Szepetowski P; Simon M P; Jeanteur P; Birnbaum D; Gaudray P
BCL-1 participates in the 11q13 amplification found in breast cancer.
Oncogene 1990;5(1):147-9.
1989: Adnane J; Gaudray P; Simon M P; Simony-Lafontaine J; Jeanteur P; Theillet C
Proto-oncogene amplification and human breast tumor phenotype.
Oncogene 1989;4(11):1389-95.
1989: Theillet C; Le Roy X; De Lapeyrière O; Grosgeorges J; Adnane J; Raynaud S D; Simony-Lafontaine J; Goldfarb M; Escot C; Birnbaum D
Amplification of FGF-related genes in human tumors: possible involvement of HST in breast carcinomas.
Oncogene 1989;4(7):915-22.
1989: Mariani-Costantini R; Theillet C; Hutzell P; Merlo G; Schlom J; Callahan R
In situ detection of c-myc mRNA in adenocarcinomas, adenomas, and mucosa of human colon.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1989;37(3):293-8.
1988: Lidereau R; Mathieu-Mahul D; Escot C; Theillet C; Champeme M H; Cole S; Mauchauffe M; Ali I; Amione J; Callahan R
Genetic variability of proto-oncogenes for breast cancer risk and prognosis.
Biochimie 1988;70(7):951-9.
1988: Mariani-Costantini R; Escot C; Theillet C; Gentile A; Merlo G; Lidereau R; Callahan R
In situ c-myc expression and genomic status of the c-myc locus in infiltrating ductal carcinomas of the breast.
Cancer research 1988;48(1):199-205.
1987: Ali I U; Lidereau R; Theillet C; Callahan R
Reduction to homozygosity of genes on chromosome 11 in human breast neoplasia.
Science (New York, N.Y.) 1987;238(4824):185-8.
1986: Thor A; Ohuchi N; Hand P H; Callahan R; Weeks M O; Theillet C; Lidereau R; Escot C; Page D L; Vilasi V
ras gene alterations and enhanced levels of ras p21 expression in a spectrum of benign and malignant human mammary tissues.
Laboratory investigation; a journal of technical methods and pathology 1986;55(6):603-15.
1986: Theillet C; Lidereau R; Escot C; Hutzell P; Brunet M; Gest J; Schlom J; Callahan R
Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas.
Cancer research 1986;46(9):4776-81.
1986: Lidereau R; Escot C; Theillet C; Champeme M H; Brunet M; Gest J; Callahan R
High frequency of rare alleles of the human c-Ha-ras-1 proto-oncogene in breast cancer patients.
Journal of the National Cancer Institute 1986;77(3):697-701.
1986: Escot C; Theillet C; Lidereau R; Spyratos F; Champeme M H; Gest J; Callahan R
Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(13):4834-8.
1985: Lidereau R; Mathieu-Mahul D; Theillet C; Renaud M; Mauchauffé M; Gest J; Larsen C J
Presence of an allelic EcoRI restriction fragment of the c-mos locus in leukocyte and tumor cell DNAs of breast cancer patients.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(20):7068-70.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Charles Theillet

Research Profile (preview)

Disorders

Physiology

Chemicals & Drugs

Anatomy

Genes & Molecular Sequences

Procedures

Concepts & Ideas

Phenomena

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Charles Theillet (preview)

All Publications